The launch in Thailand marks Wegovy’s entry into the Southeast Asian market. Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm ...

BANGKOK, April 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

The health sector sees dynamic shifts with Thailand's poultry industry set for growth, breakthrough breast cancer treatments ...

If you’re exploring diabetes or weight-loss medications, Ozempic and Wegovy have become two popular options of injectable treatments. Both medications support blood sugar control and weight loss ...

“If in fact they keep their commitment, will Novo Nordisk substantially lower the list price of Ozempic and Wegovy in the U.S.?” Sanders, who chairs the committee, asked. Jørgensen initially ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...

The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.

Wegovy (semaglutide) is a brand-name subcutaneous injection (shot) prescribed for weight loss and to lower the risk of cardiovascular problems in some people. As with other drugs, Wegovy can cause ...

WASHINGTON — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...